Stephen Beard Sells 2,762 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 2,762 shares of Adtalem Global Education stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $130.14, for a total value of $359,446.68. Following the transaction, the chief executive officer owned 426,562 shares in the company, valued at $55,512,778.68. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

NYSE CVSA opened at $128.23 on Friday. The stock has a market capitalization of $4.36 billion, a P/E ratio of 19.97, a PEG ratio of 1.07 and a beta of 0.62. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The firm’s fifty day moving average is $120.70. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26.

Adtalem Global Education (NYSE:CVSA) last released its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.25. The company had revenue of $487.03 million for the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.Adtalem Global Education’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, sell-side analysts forecast that Adtalem Global Education Inc. will post 8.04 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Barrington Research reiterated an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research report on Monday, June 8th. Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Truist Financial boosted their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.